An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

Chakshu Research

Status and phase: Unknown; Phase 2

Conditions: Asteroid Hyalosis

Treatments: Drug: C-KAD Ophthalmic Solution

Study type: Interventional

Funder types: Industry

Identifiers

NCT00825942

PCK-0108

Details and patient eligibility

About

To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Enrollment: 20 estimated patients

Sex: All

Ages: 21 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Presence of asteroid hyalosis

Exclusion criteria

• Active ocular infection
• Glaucoma
• Ocular hypertension
• Ocular inflammatory disorders

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

C-KAD Ophthalmic Solution

Experimental group

Treatment:

Drug: C-KAD Ophthalmic Solution